We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
-16.77%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$8.98B
AUM Growth
-$2.7B
Cap. Flow
-$396M
Cap. Flow %
-4.41%
Top 10 Hldgs %
20.42%
Holding
2,199
New
186
Increased
854
Reduced
751
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Healthcare 15.94%
3 Financials 12.88%
4 Communication Services 8.79%
5 Industrials 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNS
2026
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$3K ﹤0.01%
+430
New +$3.73K
DSKE
2027
DELISTED
Daseke, Inc. Common Stock
DSKE
$3K ﹤0.01%
2,170
-3,250
-60% -$9.58K
EXPR
2028
DELISTED
Express, Inc.
EXPR
$3K ﹤0.01%
+103
New +$7.55K
PRTK
2029
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$3K ﹤0.01%
+980
New +$3.62K
DBD
2030
DELISTED
Diebold Nixdorf Incorporated
DBD
$3K ﹤0.01%
960
-790
-45% -$6.69K
SRNE
2031
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$3K ﹤0.01%
+1,840
New +$5.3K
CLVS
2032
DELISTED
Clovis Oncology, Inc.
CLVS
$3K ﹤0.01%
470
-47,830
-99% -$384K
LDL
2033
DELISTED
Lydall, Inc.
LDL
$3K ﹤0.01%
+490
New +$8.01K
CHL
2034
DELISTED
China Mobile Limited
CHL
$3K ﹤0.01%
92
NTT
2035
DELISTED
Nippon Telegraph & Telephone
NTT
$3K ﹤0.01%
132
+66
+100% +$1.5K
LJPC
2036
DELISTED
La Jolla Pharmaceutical Company
LJPC
$3K ﹤0.01%
+760
New +$4.8K
AVTX icon
2037
Avalo Therapeutics
AVTX
$1.06B
0
BTI icon
2038
British American Tobacco
BTI
$123B
$2K ﹤0.01%
54
CBUS icon
2039
Cibus
CBUS
$145M
$2K ﹤0.01%
+14
New +$3.89K
CROX icon
2040
Crocs
CROX
$6.64B
$2K ﹤0.01%
+100
New +$3.19K
HMC icon
2041
Honda
HMC
$41.1B
$2K ﹤0.01%
104
MDRR
2042
Medalist Diversified Inc
MDRR
$2K ﹤0.01%
71
+22
+45% +$1.11K
IMDX
2043
Insight Molecular Diagnostics
IMDX
$157M
$2K ﹤0.01%
+46
New +$2.25K
PGEN icon
2044
Precigen
PGEN
$2.53B
$2K ﹤0.01%
607
RES icon
2045
RPC Inc
RES
$1.36B
$2K ﹤0.01%
+980
New +$3.63K
SLDB icon
2046
Solid Biosciences
SLDB
$918M
$2K ﹤0.01%
53
TPST icon
2047
Tempest Therapeutics
TPST
$16.6M
$2K ﹤0.01%
+2
New +$2.92K
TWI icon
2048
Titan International
TWI
$460M
$2K ﹤0.01%
1,190
-10
-0.8% -$26
WHLR
2049
Wheeler Real Estate Investment Trust
WHLR
$390K
0
LTRPA
2050
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$2K ﹤0.01%
1,200
+594
+98% +$2.98K

Similar funds

Nisa Investment Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Nisa Investment Advisors held 2,199 positions worth $8.98B, down 23% from $11.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nisa Investment Advisors withdrew a net $396M in Q1 2020, closing 128 positions and reducing 751 holdings. Its most notable exit was Wellcare Health Plans, Inc., an estimated $8.36M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Nisa Investment Advisors opened a new position in Uber worth $3.23M.

  • Nisa Investment Advisors's largest Q1 2020 buy was Uber: 115,800 shares worth $3.23M.
  • Nisa Investment Advisors added most to Berkshire Hathaway Class B in Q1 2020, an estimated $10.4M increase.
  • Nisa Investment Advisors's biggest Q1 2020 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $23.3M.
  • Nisa Investment Advisors fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $8.36M.
  • Nisa Investment Advisors's ten largest holdings make up 20% of its $8.98B portfolio in Q1 2020.
  • Nisa Investment Advisors opened 186 new positions and closed 128 in Q1 2020.
  • Nisa Investment Advisors's portfolio value fell 23% quarter-over-quarter to $8.98B.

Based on Nisa Investment Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.